RIFADINE 300 mg, gélule, ANSATIPINE 150 mg, gélule
RIPH_2019_01
Phase 3 small_molecule active
Quick answer
RIFADINE 300 mg, gélule, ANSATIPINE 150 mg, gélule for Adult with an staphylococcal prosthetic joint infection treated with debridement, antibiotics and implant retention (DAIR strategy) is a Phase 3 program (small_molecule) at Tour Hekla with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tour Hekla
- Indication
- Adult with an staphylococcal prosthetic joint infection treated with debridement, antibiotics and implant retention (DAIR strategy)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active